Evolución rápida de la resistencia a drogas antirretrovirales en 2 pacientes infectados por VIH-1

Díaz Torres, Héctor Manuel; Machado Zaldívar, Liuber Yans; Dubed Echevarría, Marta; Martínez Fernández, Liodelvio; Ruiz Gutiérrez, Nancy María; Blanco de Armas, Madeline.
Rev. cuba. med ; 53(2): 127-133, abr.-jun. 2014.
Artigo em Espanhol | LILACS | ID: lil-722965

Documentos relacionados

  1. HIV drug resistance in various body compartments.
  2. Comparing effectiveness of first-line antiretroviral therapy between peri-urban and rural clinics in KwaZulu-Natal, South Africa.
  3. Resistance Analyses in Highly Treatment-Experienced People With Human Immunodeficiency Virus (HIV) Treated With the Novel Capsid HIV Inhibitor Lenacapavir.
  4. Bictegravir/emtricitabine/tenofovir alafenamide in patients with genotypic NRTI resistance.
  5. Analysis of ART effects and drug resistance in adult HIV/AIDS patients in Meigu County, Liangshan Prefecture, China.
  6. Impact of low-level viremia with drug resistance on CD4 cell counts among people living with HIV on antiretroviral treatment in China.
  7. Antiretrovirals to CCR5 CRISPR/Cas9 gene editing - A paradigm shift chasing an HIV cure.
  8. Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine.
  9. Persistent low-level viraemia in antiretroviral treatment-experienced patients is not linked to viral resistance or inadequate drug concentrations.
  10. HIV-1 persistent viremia is frequently followed by episodes of low-level viremia.